| URN | urn:agi-llid:409 |
|---|---|
| Total Entities | 0 |
| Connectivity | 1000 |
| Name | Arrb2 |
| Description | arrestin, beta 2 |
| Notes | Members of arrestin/beta-arrestin protein family are thought to participate in agonist-mediated desensitization of G-protein-coupled receptors and cause specific dampening of cellular responses to stimuli such as hormones, neurotransmitters, or sensory signals. Arrestin beta 2, like arrestin beta 1, was shown to inhibit beta-adrenergic receptor function in vitro. It is expressed at high levels in the central nervous system and may play a role in the regulation of synaptic receptors. Besides the brain, a cDNA for arrestin beta 2 was isolated from thyroid gland, and thus it may also be involved in hormone-specific desensitization of TSH receptors. Multiple alternatively spliced transcript variants have been found for this gene, but the full-length nature of some variants has not been defined. [provided by RefSeq] |
| GO Molecular Function | protein complex binding |
|---|---|
| protein complex scaffold | |
| protein domain specific binding | |
| 14-3-3 protein binding | |
| clathrin binding | |
| receptor binding | |
| G-protein coupled receptor binding | |
| angiotensin receptor binding | |
| follicle-stimulating hormone receptor binding | |
| alpha-1B adrenergic receptor binding | |
| alpha-1A adrenergic receptor binding | |
| type 1 angiotensin receptor binding | |
| D1 dopamine receptor binding | |
| type 2A serotonin receptor binding | |
| protein kinase B binding | |
| mitogen-activated protein kinase binding | |
| ubiquitin protein ligase binding |
| GO Cellular Component | membrane |
|---|---|
| coated pit | |
| basolateral plasma membrane | |
| postsynaptic membrane | |
| postsynaptic density | |
| intracellular | |
| plasma membrane | |
| cytoplasm | |
| cytosol | |
| cytoplasmic vesicle | |
| endocytic vesicle | |
| nucleus | |
| dendritic spine |
| GO Biological Process | follicle-stimulating hormone signaling pathway |
|---|---|
| negative regulation of toll-like receptor signaling pathway | |
| negative regulation of natural killer cell mediated cytotoxicity | |
| receptor internalization | |
| regulation of cAMP biosynthetic process | |
| positive regulation of ERK1 and ERK2 cascade | |
| negative regulation of GTPase activity | |
| regulation of cAMP catabolic process | |
| G-protein coupled receptor internalization | |
| positive regulation of receptor internalization | |
| negative regulation of interleukin-6 production | |
| negative regulation of interleukin-12 production | |
| negative regulation of tumor necrosis factor production | |
| negative regulation of interleukin-1 beta production | |
| blood coagulation | |
| platelet activation | |
| detection of temperature stimulus involved in sensory perception of pain | |
| brain development | |
| adult walking behavior | |
| signal transduction | |
| negative regulation of signal transduction | |
| positive regulation of protein kinase B signaling | |
| negative regulation of release of cytochrome c from mitochondria | |
| regulation of G-protein coupled receptor protein signaling pathway | |
| desensitization of G-protein coupled receptor protein signaling pathway by arrestin | |
| regulation of androgen receptor signaling pathway | |
| G-protein coupled receptor signaling pathway | |
| Notch signaling pathway | |
| transforming growth factor beta receptor signaling pathway | |
| positive regulation of synaptic transmission, dopaminergic | |
| cell chemotaxis | |
| negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | |
| negative regulation of smooth muscle cell apoptotic process | |
| positive regulation of calcium ion transport | |
| positive regulation of DNA biosynthetic process | |
| positive regulation of protein phosphorylation | |
| positive regulation of peptidyl-serine phosphorylation | |
| positive regulation of peptidyl-tyrosine phosphorylation | |
| positive regulation of protein ubiquitination | |
| negative regulation of protein ubiquitination | |
| regulation of protein phosphorylation | |
| negative regulation of NF-kappaB transcription factor activity | |
| transcription from RNA polymerase II promoter | |
| protein ubiquitination | |
| proteasome-mediated ubiquitin-dependent protein catabolic process | |
| transport | |
| protein transport | |
| endocytosis |
| Pathway | Macrophage Survival through CCR5 and CXCR4 Mediated Signaling in HIV Type 1 Infection |
|---|---|
| Induction of Apoptosis and Immediate Early Gene Activation in Hippocampal Neurons Following Seizures | |
| Myocardial Remodeling in Myocardial Ischemia | |
| WHIM Syndrom Overview | |
| dopamine signaling pathway | |
| angiotensin II signaling pathway via AT1 receptor | |
| kinin signaling pathway | |
| epinephrine signaling pathway via adrenergic receptor beta | |
| dopamine signaling pathway |
| Group | follicle-stimulating hormone signaling pathway |
|---|---|
| negative regulation of toll-like receptor signaling pathway | |
| negative regulation of natural killer cell mediated cytotoxicity | |
| receptor internalization | |
| regulation of cAMP biosynthetic process | |
| positive regulation of ERK1 and ERK2 cascade | |
| negative regulation of GTPase activity | |
| regulation of cAMP catabolic process | |
| G-protein coupled receptor internalization | |
| positive regulation of receptor internalization | |
| negative regulation of interleukin-6 production | |
| negative regulation of interleukin-12 production | |
| negative regulation of tumor necrosis factor production | |
| negative regulation of interleukin-1 beta production | |
| blood coagulation | |
| platelet activation | |
| detection of temperature stimulus involved in sensory perception of pain | |
| brain development | |
| adult walking behavior | |
| signal transduction | |
| negative regulation of signal transduction | |
| positive regulation of protein kinase B signaling | |
| negative regulation of release of cytochrome c from mitochondria | |
| regulation of G-protein coupled receptor protein signaling pathway | |
| desensitization of G-protein coupled receptor protein signaling pathway by arrestin | |
| regulation of androgen receptor signaling pathway | |
| G-protein coupled receptor signaling pathway | |
| Notch signaling pathway | |
| transforming growth factor beta receptor signaling pathway | |
| positive regulation of synaptic transmission, dopaminergic | |
| cell chemotaxis | |
| negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | |
| negative regulation of smooth muscle cell apoptotic process | |
| positive regulation of calcium ion transport | |
| positive regulation of DNA biosynthetic process | |
| positive regulation of protein phosphorylation | |
| positive regulation of peptidyl-serine phosphorylation | |
| positive regulation of peptidyl-tyrosine phosphorylation | |
| positive regulation of protein ubiquitination | |
| negative regulation of protein ubiquitination | |
| regulation of protein phosphorylation | |
| negative regulation of NF-kappaB transcription factor activity | |
| transcription from RNA polymerase II promoter | |
| protein ubiquitination | |
| proteasome-mediated ubiquitin-dependent protein catabolic process | |
| transport | |
| protein transport | |
| endocytosis | |
| protein complex binding | |
| protein complex scaffold | |
| protein domain specific binding | |
| 14-3-3 protein binding | |
| clathrin binding | |
| receptor binding | |
| G-protein coupled receptor binding | |
| angiotensin receptor binding | |
| follicle-stimulating hormone receptor binding | |
| alpha-1B adrenergic receptor binding | |
| alpha-1A adrenergic receptor binding | |
| type 1 angiotensin receptor binding | |
| D1 dopamine receptor binding | |
| type 2A serotonin receptor binding | |
| protein kinase B binding | |
| mitogen-activated protein kinase binding | |
| ubiquitin protein ligase binding | |
| membrane | |
| coated pit | |
| basolateral plasma membrane | |
| postsynaptic membrane | |
| postsynaptic density | |
| intracellular | |
| plasma membrane | |
| cytoplasm | |
| cytosol | |
| cytoplasmic vesicle | |
| endocytic vesicle | |
| nucleus | |
| dendritic spine | |
| Secreted proteins | |
| Biofluids assayable substances |
| LocusLink ID | 409 |
|---|---|
| 216869 | |
| 25388 |
| Cell Localization | Cytoplasm |
|---|---|
| Nucleus | |
| Cell membrane | |
| Membrane | |
| Clathrin-coated pit | |
| Cytoplasmic vesicle |
| GO ID | 0071889 |
|---|---|
| 0031748 | |
| 0001664 | |
| 0031691 | |
| 0031692 | |
| 0031701 | |
| 0031762 | |
| 0051019 | |
| 0032403 | |
| 0032947 | |
| 0019904 | |
| 0043422 | |
| 0005102 | |
| 0031702 | |
| 0031826 | |
| 0031625 | |
| 0002031 | |
| 0007219 | |
| 0007628 | |
| 0007596 | |
| 0007420 | |
| 0060326 | |
| 0002032 | |
| 0050965 | |
| 0042699 | |
| 0034260 | |
| 0032088 | |
| 0032691 | |
| 0032695 | |
| 0032715 | |
| 0045953 | |
| 0031397 | |
| 0034392 | |
| 0034122 | |
| 0032720 | |
| 0030168 | |
| 0070374 | |
| 0051928 | |
| 0050731 | |
| 0051897 | |
| 0031398 | |
| 0002092 | |
| 0032226 | |
| 0043161 | |
| 0015031 | |
| 0016567 | |
| 0031623 | |
| 0060765 | |
| 0006366 | |
| 0007179 | |
| 0016323 | |
| 0005905 | |
| 0005737 | |
| 0031410 | |
| 0005829 | |
| 0043197 | |
| 0030139 | |
| 0005634 | |
| 0005886 | |
| 0014069 | |
| 0045211 | |
| 0007186 | |
| 0006897 | |
| 0043154 | |
| 0090201 | |
| 0009968 | |
| 2000573 | |
| 0033138 | |
| 0001934 | |
| 0008277 | |
| 0001932 | |
| 0007165 | |
| 0006810 | |
| 0005622 | |
| 0016020 | |
| 0030276 | |
| 0030817 | |
| 0030820 | |
| 0016023 | |
| 0007600 | |
| 0005515 | |
| 0050896 |
| Alias | ARB2 |
|---|---|
| ARR2 | |
| BARR2 | |
| beta-arrestin-2 | |
| arrestin 3 | |
| arrestin beta-2 | |
| AI326910 | |
| AW122872 | |
| DN-491F10.4 | |
| beta arr2 | |
| BARRES | |
| Beta-arrestin II | |
| RP23-42p20.7 | |
| DKFZp686L0365 | |
| LOC216869 | |
| MGC105502 | |
| OTTMUSP00000006315 | |
| OTTMUSP00000006318 | |
| OTTMUSP00000006316 | |
| ARRB2 | |
| arrestin 2 | |
| arrestin beta 2 | |
| arrestin beta II | |
| arrestin II | |
| beta-arrestin2 | |
| arrestin, beta 2 | |
| Beta-arrestin 2 | |
| Beta-arrestin 2 (Arrestin, beta 2) |
| Mouse chromosome position | 11 42.99 cM |
|---|---|
| 11 45.0 cM |
| OMIM ID | 107941 |
|---|
| Rat chromosome position | 10q24 |
|---|
| Hugo ID | 712 |
|---|
| Human chromosome position | 17p13 |
|---|
| Swiss-Prot Accession | P32121 |
|---|---|
| Q59EM5 | |
| K7ENA6 | |
| J3JS97 | |
| Q91YI4 | |
| P29067 | |
| B4DLW0 | |
| B5B0C0 | |
| B7WPL3 | |
| D3DTK2 | |
| H0Y688 | |
| Q0Z8D3 | |
| Q2PP19 | |
| Q6ICT3 | |
| Q8N7Y2 | |
| Q9UEQ6 | |
| Q3TCM2 | |
| Q5F2D8 | |
| Q5F2E0 | |
| Q68DZ5 | |
| Q3TRC8 | |
| Q3UCU5 | |
| Q5F2D9 |
| PIR ID | S18984 |
|---|---|
| A59279 |
| Unigene ID | Hs.435811 |
|---|---|
| Mm.203747 | |
| Rn.32973 |
| KEGG ID | hsa:409 |
|---|---|
| mmu:216869 | |
| rno:25388 |
| Swiss-Prot ID | ARRB2_HUMAN |
|---|---|
| ARRB2_RAT | |
| ARRB2_MOUSE | |
| D3DTK2_HUMAN | |
| B5B0C0_HUMAN |
| Ensembl ID | ENSG00000141480 |
|---|---|
| ENSP00000403701 | |
| ENST00000412477 | |
| ENSP00000466857 | |
| ENST00000575877 | |
| ENSP00000341895 | |
| ENST00000346341 | |
| ENSP00000269260 | |
| ENST00000269260 | |
| ENSMUSG00000060216 | |
| ENSMUSP00000104208 | |
| ENSMUST00000108568 | |
| ENSMUSP00000078065 | |
| ENSMUST00000079056 | |
| ENSMUSP00000099623 | |
| ENSMUST00000102563 | |
| ENSMUSP00000099624 | |
| ENSMUST00000102564 | |
| ENSRNOG00000019308 | |
| ENSRNOP00000026207 | |
| ENSRNOT00000026207 |
| Homologene ID | 3183 |
|---|
| Organism | Homo sapiens |
|---|---|
| Mus musculus | |
| Rattus norvegicus |
| MGI ID | 99474 |
|---|
| RGD ID | 2157 |
|---|
| MedScan ID | 409 |
|---|
| IPI ID | IPI00231135 |
|---|---|
| IPI00180375 | |
| IPI00783893 | |
| IPI00786904 | |
| IPI00130214 | |
| IPI00647964 | |
| IPI00395607 | |
| IPI00795723 | |
| IPI00793794 | |
| IPI00648751 | |
| IPI00777302 |